NasdaqGS - Nasdaq Real Time Price USD
Krystal Biotech, Inc. (KRYS)
136.80
-2.67
(-1.91%)
At close: May 7 at 4:00:00 PM EDT
138.33
+1.53
+(1.12%)
After hours: May 7 at 6:33:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 5 |
| Avg. Estimate | 1.26 | 1.41 | 5.88 | 10.49 |
| Low Estimate | 0.95 | 1.13 | 4.8 | 8.61 |
| High Estimate | 1.64 | 1.72 | 6.69 | 14.17 |
| Year Ago EPS | 0.93 | 1.29 | 4.18 | 5.88 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 10 | 10 |
| Avg. Estimate | 96.19M | 107.18M | 417.15M | 608.46M |
| Low Estimate | 92.6M | 103.2M | 404.1M | 509.23M |
| High Estimate | 105M | 118M | 448M | 765.5M |
| Year Ago Sales | 70.28M | 83.84M | 290.51M | 417.15M |
| Sales Growth (year/est) | 36.86% | 27.84% | 43.59% | 45.86% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.99 | 1.33 | 1.85 | 1.52 |
| EPS Actual | 0.93 | 1.29 | 1.53 | 1.2 |
| Difference | -0.06 | -0.04 | -0.32 | -0.32 |
| Surprise % | -5.88% | -3.18% | -17.39% | -21.05% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.26 | 1.41 | 5.88 | 10.49 |
| 7 Days Ago | 1.85 | 1.9 | 7.65 | 10.53 |
| 30 Days Ago | 1.55 | 1.81 | 7.58 | 10.77 |
| 60 Days Ago | 1.55 | 1.81 | 7.58 | 10.77 |
| 90 Days Ago | 1.59 | 1.61 | 6.75 | 7.14 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KRYS | 35.19% | 8.99% | 40.65% | 78.49% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 5/7/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/6/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/29/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/28/2025 |
| Initiated | Jefferies: Buy | 3/5/2025 |
Related Tickers
PTCT PTC Therapeutics, Inc.
40.76
+12.63%
CYTK Cytokinetics, Incorporated
33.04
-2.74%
ACLX Arcellx, Inc.
52.94
+0.27%
PCVX Vaxcyte, Inc.
29.00
-0.82%
RNA Avidity Biosciences, Inc.
26.17
-0.34%
ASND Ascendis Pharma A/S
160.99
-1.14%
APLS Apellis Pharmaceuticals, Inc.
17.99
-5.91%
RARE Ultragenyx Pharmaceutical Inc.
33.42
-4.68%
BPMC Blueprint Medicines Corporation
99.80
+0.65%
MDGL Madrigal Pharmaceuticals, Inc.
298.83
+1.25%